It is one of the most common types of leukemias in adults; however, the disease comprises only about 1% of all cancers. There are a variety of treatment options available for patients with AML, with more clinical trials evaluating new therapies in the pipeline. In this episode of the “CURE talks Cancer” podcast, we spoke with Dan Pollyea, from the University of Colorado Cancer Center, about these treatment options.